1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. TRINITY BIOTECH PLC - ADR
Trinity Biotech Plc - ADR
XNAS: TRIB
Download real time
6.860.82(13.58%)
86.93% Fall from 52W High
33,814
XNAS Volume
High volume+gain today

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Board Meeting
The next board meeting for Trinity Biotech PLC (ADR) is on 14 Oct 2026 for the purpose of Trinity Biotech PLC Annual General Meeting for 2026See details

Trinity Biotech PLC (ADR) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Trinity Biotech PLC (ADR) quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue Trinity Biotech PLC (ADR) Dec-2025 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • NEUTRAL

    Quarterly Net Profit Trinity Biotech PLC (ADR) Dec-2025 Quarterly Net Profit is $0 Million which is growth of 0% YoY.

Trinity Biotech Plc - ADR, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphDec '25Jun '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22
Operating Rev.
--15.915.215.814.713.414.713.914.81819.515.4
Cost Of Rev.
--119.810.19.28.910.48.99.311.817.59.8
Gross Profit
--4.95.35.75.54.64.355.66.225.6
⌄
--13.47.57.48.68.18.89.19.5116.86.9
Operating Profit
---8.6-2.2-1.7-3-3.5-4.5-4-3.9-4.8-4.8-1.3
⌄
---7.9-2.2-1.9-0.2-0.8-2-3.8-2.410.9-1.9-8.3
Profit Before Tax
---15.8-4.8-6.9-3.3-5.5-6.5-18.6-6.3-10.1-8.9-10.2
Tax
--0.6-0-0.10.10.2-0.3-0-0-0
⌄
---17-4.8-6.8-3.3-5.5-6.7-6-5.8-10.1-9-9.7
Diluted NI Avail to Com Stockholders Ann.
---17-4.8-6.8-3.3-5.5-6.7-6-5.8-10.1-9-9.7
Basic EPS
---38.4-13.8-21.8-11.2-21.6-26.3-23.4-22.8-39.8-35.3-42.6
Diluted EPS After ExtraOrdinary
---35.4-12.8-21.8-11.2-18.7-26.3-30.1-24.823.7-27.3-42.4
Number Of Shares End
--0.60.40.30.30.30.30.30.30.30.30.2
Net Income Continuing Discontinued Operations
---17-4.8-6.8-3.3-5.5-6.7-6-5.8-10.1-9-9.7
Normalized Income
---15.4-4.4-6.8-3.3-4.3-6.7-7.7-6.36.1-6.9-9.6
Interest Income
---0.90.90.1-0.60.40.10.2-0.30.3
Interest
--5.83.15.40.31.42.43.82.6-112.28.3
Net Interest Income
---7.9-2.2-1.9-0.2-0.8-2-3.8-2.410.9-1.9-8.3
EBIT
---10-1.7-1.5-3-4.1-4.1-14.8-3.8-21-6.8-1.9
EBITDA
---9.6-1.1-1.3-2.3-3.7-3.9-14.3-3.2-20.4-6-1.6
Reconciled Cost Of Rev.
--119.810.19.28.910.48.99.311.817.59.8
Reconciled Depr.
--0.40.60.20.70.50.20.50.60.70.70.3
Profit From Continuing Operations
---17-4.8-6.8-3.3-5.5-6.7-6-5.8-10.1-9-9.7
Normalized EBITDA
---8.4-0.8-1.3-2.3-2.5-3.9-3.5-3.2-4.2-3.7-1.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Trinity Biotech PLC (ADR) competitor comparison and performance snapshot within industry

Trinity Biotech PLC (ADR) annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Annual Revenue Trinity Biotech PLC (ADR) Dec-2025 Annual Revenue is $44 Million which is growth of -28.9% YoY.

  • NEGATIVE

    Annual Net Profit Trinity Biotech PLC (ADR) Dec-2025 Annual Net Profit is $-37 Million which is growth of -17.6% YoY.

Trinity Biotech Plc - ADR, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-16.3%
-15.6%
 43.861.656.874.89310290.49799.199.6100.2
Cost Of Rev. Ann.
-20.1%
-12.8%
 26.940.137.452.754.953.452.355.657.356.154
Gross Profit Ann.
-8.6%
-19%
 16.921.419.522.138.148.638.141.541.943.546.2
Operating Exp. Ann.
-5%
0%
 28.336.935.43329.228.337.934.837.835.333
Operating Profit Ann.
-
-
 -11.4-15.5-15.9-10.98.920.30.26.74.18.213.3
⌄
-
-
 -13.1-13.1-9-11.3-5.9-6.7-5.9-3-2.2-2.39.4
Other Exp. Ann.
-
-
 -12.7-3.9-12-19-2.3-20.2-24.3-26.9-41.8-480.2
PBT Ann.
-
-
 -37.2-30.7-36.9-41.20.8-6.6-30-23.2-39.9-42.122.9
Tax Ann.
-
-
 0.20.5-0.1-0.2-0.2-0.6-1-0.5-1.2-3.61.1
⌄
-
-
 -37.4-31.8-24-410.9-6.4-28.9-22.1-40.3-100.621.8
Diluted NI Avail to Com Stockholders Ann.
-
-
 -37.4-31.8-24-410.9-6.4-28.9-22.1-40.3-100.621.8
EPS Ann.
-
-
 -60-54-96-1806-48-210-156-282-660144
Diluted EPS Ann.
-
-
 -60-54-96-1806-48-210-156-282-66072
Number Of Shares End
-
-
 -0.60.30.30.10.10.10.10.10.20.2
Total Exp. Ann.
-13.6%
-7.5%
 55.277.172.885.784.181.790.390.395.191.487
Net Income Continuing Discontinued Operations Ann.
-
-
 -37.4-31.8-24-410.9-6.4-28.9-22.1-40.3-100.621.8
Normalized Income Ann.
-
-
 -26.3-27.8-24.9-22.12.912.3-5.53.71.85.521.8
Interest Income Ann.
-
-
 0.200.50.70.80.90.5
Interest Ann.
4.4%
19%
 13.11210.211.55.55.56.65.15.45.44.1
EBITDA Ann.
-
-
 -21.4-16.9-25-27.392-18.5-14-29.3-30.632.6
Reconciled Cost Of Rev. Ann.
-20.1%
-12.8%
 26.940.137.452.754.953.449.854.357.35351
Reconciled Depr. Ann.
5.5%
-2.7%
 2.71.91.82.32.73.14.94.15.26.15.6
Profit From Continuing Operations Ann.
-
-
 -37.4-31.8-24-410.9-6.4-28.9-22.1-40.3-100.621.8
Normalized EBITDA Ann.
-
-
 -8.7-13-13-8.411.222.25.81312.517.632.6
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
-28.9%
2Y CAGR
-12.2%
3Y CAGR
-16.3%
5Y CAGR
-15.6%
7Y CAGR
-10.7%
10Y CAGR
-7.9%
Total Revenue Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
-23.3%
2Y CAGR
-10.6%
3Y CAGR
-5%
7Y CAGR
-2.9%
10Y CAGR
-1.5%
Operating Expenses Annual Cr is falling faster than historical averages.

Trinity Biotech PLC (ADR) balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund Trinity Biotech PLC (ADR) Dec-2025 Total Shareholders Fund is $-72 Million which is growth of -104.6% YoY.

  • POSITIVE

    Total Assets Trinity Biotech PLC (ADR) Dec-2025 Total Assets is $105 Million which is growth of 1.8% YoY.

Trinity Biotech Plc - ADR, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
4.5%
-4.2%
105.2103.359.492.1118.9130.4131.1151.7193249.6363.7
⌄
23.4%
6%
177.2138.583.494.3119.2132.6126.4107.6127.8140.9149.8
⌄
-
-
-72-35.2-24-2.2-0.3-2.24.744.165.2108.7213.9
Total Capitalization Ann.
-
-
-55.752.630.755.9-0.380.586.7125.4158.2201305.4
Tangible Assets Ann.
-
-
-129-86.5-40.2-37.4-36.3-36.1-38.9-8.90.421.552.5
Working Capital Ann.
-
-
-105.392429.3-27.856.251.969.191.4108.2143.1
Invested Capital Ann.
-2.1%
-8.8%
52.652.830.956.18383.486.7125.4158.2201305.4
Tangible Book Value Ann.
-
-
-129-86.5-40.2-37.5-36.3-36.1-38.9-8.90.421.552.5
Borrowings Ann.
24.1%
5.8%
138100.867.472.299.2104.3102.282.393.893.292.8
Net Debt Ann.
32.2%
15.4%
119.482.851.251.757.458.366.851.135.415.1-
Share Issued Ann.
32.8%
32.1%
386.8371.8165.916596.296.296.296.296.296.298.5
Number Of Shares End
-
-
-0.60.30.30.10.10.10.10.10.20.2
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
1.8%
2Y CAGR
33.1%
3Y CAGR
4.5%
5Y CAGR
-4.2%
7Y CAGR
-5.1%
10Y CAGR
-11.7%
Total Assets Annual growth is stable compared to historical averages.
Total Current Liabilities Ann.
1Y CHG
339.9%
2Y CAGR
206.8%
3Y CAGR
101.3%
5Y CAGR
39.1%
7Y CAGR
34.6%
10Y CAGR
21.5%
Total Current Liabilities Annual Cr growth is higher than historical averages.

Trinity Biotech PLC (ADR) ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Trinity Biotech PLC (ADR) Book Value Per Share is $-89 which is growth of -56.3% YoY.

  • NEUTRAL

    ROE Trinity Biotech PLC (ADR) ROE is 0% which is growth of 0% YoY.

Trinity Biotech Plc - ADR, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
-35.86%-39.07%-31.70%-38.87%0.70%-4.89%-20.45%-12.82%-18.20%-32.82%7.19%
ROE Ann. %
-
-
------512.27%-118.58%-40.44%-46.31%-62.38%10.61%
ROIC %
-
-
----30.70.3-8.4-18.4-16.2-22.9-38.90.9
OPM Ann. %
-
-
-26.07%-25.17%-28.05%-14.61%9.57%19.89%0.20%6.91%4.12%8.21%13.22%
Inventory Turnover Ratio Ann.
-11.2%
-3.8%
1.421.821.91.71.71.81.81.71.6
Asset Turnover Ann. %
-17%
-12.9%
0.40.80.80.70.80.80.60.60.50.30.3
Working Capital Turnover Ann.
-
-
-0.46.82.42.6-3.31.81.71.41.10.90.7
Quick Ratio Ann.
-57.5%
-44.5%
0.10.61.11.30.41.923.23.63.96.1
Current Ratio Ann.
-51.9%
-37.3%
0.31.32.62.70.73.13.74.95.35.38.1
Interest Coverage Ratio Ann.
-
-
-1.8-1.6-2.6-2.61.1-0.2-3.6-3.6-6.4-6.86.6
LT Debt To Equity Ann.
-
-
------21.21.91.40.90.4
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Current Ratio Ann.
1Y CHG
-76.9%
2Y CAGR
-66%
3Y CAGR
-51.9%
5Y CAGR
-37.3%
7Y CAGR
-32.9%
10Y CAGR
-28.1%
Current Ratio Annual is falling faster than historical averages.

Trinity Biotech PLC (ADR) cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Trinity Biotech PLC (ADR) Dec-2025 Cash From Operating Activity is $-6 Million which is growth of -41.5% YoY.

  • NEGATIVE

    Net Cash Flow Trinity Biotech PLC (ADR) Dec-2025 Net Cash Flow is $-0 Million which is growth of -106.1% YoY.

Trinity Biotech Plc - ADR, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-
-
-5.9-4.2-11.6-0.913.223.85.47.29.310.213.2
⌄
-
-
-6.2-2324.8-6-8.7-10.2-11.9-17.4-16.2-21.9-27.7
⌄
-
-
12.128.8-16-12.3-6-2.7-7.5-16.9-12.6-13.4107.5
Cash Plus Cash Eqv. End Of Year Ann.
-8.2%
-28.5%
5.15.23.76.625.927.316.430.357.677.1102
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-0.11.7-2.8-19.2-1.510.8-14-27-19.6-2593
Cash Plus Cash Eqv. Begin Of Year Ann.
-41.4%
-20.5%
5.23.76.625.927.316.430.357.677.11029.1
Income Tax Paid Supplemental Data Ann.
-
-
-----------
Interest Paid Supplemental Data Ann.
-
-
-----------
Capex Ann.
-
-
-6.2-10.1-2.7-6-8.7-10.2-11.9-17.4-16.2-21.9-27.7
Issuance Of Capital Stock Ann.
-71.3%
-
0.67.425.3----0.92.9
Issuance Of Debt Ann.
-46.9%
27.2%
1530.251001.84.50.50.1116.5
Repayment Of Debt Ann.
-
-
-3.2-2.5-12.4-124-2.9-3.2-3.5-12.4-0.3-0.3-0.1
Repurchase Of Capital Stock Ann.
-
-
------0.4-7.8-9.3-
Free Cash Flow Ann.
-
-
-12.2-14.3-14.3-6.94.613.6-6.4-10.2-6.9-11.7-14.5
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
-58%
10Y CAGR
-19.6%
Cash from Financing Annual Activity is falling faster than historical averages.
×